Previous close | 1.0500 |
Open | 1.0000 |
Bid | 0.7000 |
Ask | 1.1000 |
Strike | 27.00 |
Expiry date | 2024-08-16 |
Day's range | 1.0000 - 1.0500 |
Contract range | N/A |
Volume | |
Open interest | 52 |
New Findings from Myriad Genetics Reveal One-Third of Americans Say Election Season Affects Their Mental HealthSALT LAKE CITY, June 24, 2024 (GLOBE NEWSWIRE) -- A significant 40% of Americans report feeling ‘depressed and/or anxious’ around the election season according to the latest GeneSight® Mental Health Monitor: Special Election Series, a nationwide survey from Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine. “The results of the Special Election Surve
Key Insights Using the 2 Stage Free Cash Flow to Equity, Myriad Genetics fair value estimate is US$34.23 Current share...
Myriad Genetics (MYGN) collaborates with GSK to improve access to HRD diagnostic testing for HGSOC patients.